XYPHOS BIOSCIENCES
Xyphos Biosciences develops a CAR-T cell therapy platform called ACCEL (Advanced Cellular Control through Engineered Ligands), for treating relapsed hematological malignancies and solid tumors. The platform enables precise control of activity and targeting of universal CAR-T cell, termed convertibleCAR-T, using any tumor-specific full antibody and can add critical functionality to convertibleCAR-T cells.
XYPHOS BIOSCIENCES
Industry:
Biotechnology Health Care Medical
Founded:
2017-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.xyphosinc.com
Total Employee:
1+
Status:
Active
Contact:
(650) 243-2951
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Google Tag Manager WordPress Content Delivery Network Wordpress Plugins Global Site Tag
Similar Organizations
BionPharma
BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.
Celmed Biosciences
Celmed BioSciences develops cell therapy-based treatments for hematological, immunological, and neurological disorders.
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Henry Ford Health System
Henry Ford Health System (HFHS) is one of the nation’s leading comprehensive, integrated health systems.
Vasade Biosciences
Vasade Biosciences develops novel inhibitors of AC5 for cardioprotection against myocardial infarction and congestive heart failure.
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.xyphosinc.com
- Host name: 107.0.153.160.host.secureserver.net
- IP address: 160.153.0.107
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
